Shiny Health & Wellness Signs Asset Purchase Agreement for First Pharmacy Acquisition as Part of Retail Expansion Plans – Yahoo Finance

Share Article

(All amounts are in Canadian dollars unless otherwise stated)
TORONTO, Sept. 23, 2022 /CNW/ – Shiny Health & Wellness Corp. (“Shiny Health” or the “Company”) (TSXV: SNYB) is pleased to announce that, through its subsidiary mīhī Health & Wellness (collectively “the Company”), it has entered into a definitive Asset Purchase Agreement to complete its previously-announced acquisition of Cotton Mill Pharmacy (“Cotton Mill”) for a total purchase price of $700,000 plus approximately $135,000 in inventory. The acquisition, which was originally announced on May 16, 2022, is currently scheduled to close on October 3, 2022, subject to regulatory approvals and other customary conditions to closing. Closing of the Cotton Mill transaction will be the first pharmacy acquisition in furtherance of the Company’s broader retail expansion strategy into health and wellness. In operation since 2015, Cotton Mill is a fully independent no banner pharmacy located in Cornwall, Ontario.
“We are thrilled to begin executing on our expanded retail strategy into health and wellness as we prepare to close the acquisition of our first pharmacy in the coming weeks,” said Kevin Reed, Chairman and Chief Executive Officer. “We continue to actively build our pipeline of pharmacy targets across Ontario with the objective of becoming a trusted source for health and wellness solutions and services to improve lives.”
Acquisition Financing
To finance the acquisition, the Company has received a committed arrangement from Care Lending Group for a $600,000 secured acquisition 10-year term loan (the “Acquisition Loan”), which will be fully drawn at closing.  The Acquisition Loan will bear interest equivalent to the 5-year Government of Canada Bond rate at close plus 440 basis points and be repayable monthly in instalments of principal and interest based on a 120-month amortization schedule.  Pursuant to the Asset Purchase Agreement, $100,000 of the purchase price will be paid through a one-year vendor take-back loan at an annual interest rate of 4.0%. The Company expects to pay the balance of the purchase price (approximately $135,000 in respect of inventory) from cash on hand.
“Once the transaction closes, management’s store-level development plan will focus on improving the patient and customer experience, increasing revenue generating opportunities, and pursuing operating efficiencies to enhance margins and EBITDA,” said Mike Nadeau, Chief Operating Officer and President of Pharmacy.
Ongoing Expansion Into Retail Pharmacy
Acquiring retail pharmacies is an integral part of Shiny Health’s growth plan and merger and acquisition focus as it expands beyond retail cannabis operations. The objective is to build a network of retail pharmacies with the goal of achieving operational scale. Beyond Cotton Mill, the Company is currently evaluating five further acquisition candidates with active due diligence ongoing.
In addition, the Company has engaged the lead pharmacist and co-owner of Cotton Mill in a consulting management contract for a 12-month term from the closing date to support the Company’s ongoing pharmacy M&A objectives and operations.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Care Lending Group
Care Lending Group (CLG) is a privately held Canadian financing company offering innovative and tailored lending solutions to the healthcare and golf industries and other niche markets. With an initial portfolio in excess of $60 million, serving a significant number of customers, Care Lending Group brings deep industry expertise along with a commitment to building long-term, caring relationships.
About Shiny Health & Wellness
Shiny Health & Wellness Corp. is on a mission to help people never settle, live fully by being a trusted source for health and wellness solutions and services. The Company recently broadened its retail growth strategy beyond adult-use cannabis by establishing mīhī Health & Wellness, a new line of business focused on building a network of community pharmacies across Ontario. Striving to provide a more diverse and accessible cannabis experience for adult consumers, the Company also operates ShinyBud Cannabis Co., a well-established brand in Ontario strategically located in markets less saturated with cannabis retailers. The Company’s board and management team hold extensive retail operating experience, a key competitive differentiator in leading its growth strategy. Shiny Health trades on the TSX Venture Exchange (TSXV) under the ticker symbol SNYB. For more information, please visit
Cautionary Statement Regarding Forward-Looking Information
This news release contains statements (“forward-looking statements”) that constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward looking statements relate to future performance, events, outcomes or circumstances or are otherwise prospective in nature, are based upon internal assumptions, opinions, estimates, plans, beliefs and expectations about future conditions, developments and courses of action. They are inherently uncertain as they depend on the accuracy of such assumptions, opinions, estimates, plans, beliefs and expectations, which cannot be assured, and are subject to known and unknown risks and uncertainties that will cause actual results to differ from those indicated, suggested or anticipated in the forward-looking statements. The differences may be material and adverse to the Company.
All statements other than statements of current or historical fact constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “anticipate”, “believe”, “expect”, “intend”, “seek”, “plan”, “aim”, “budget”, “forecast”, “target”, “estimate”, “objective”, “propose”, “predict”, “potential”, “project”, “continue”, “pursue”, “may”, “will”, “might”, “should”, “could” or similar words suggesting future outcomes or events or statements regarding an outlook.
Without limiting the foregoing, this news release contains forward-looking statements pertaining to: closing of the Cotton Mill acquisition and the expected timing thereof; and Shiny Health’s growth strategy and expansion into the pharmacy sector. Forward-looking statements, and the underlying assumptions, opinions, estimates, plans, beliefs and expectations on which they are based, are inherently uncertain as they depend on future conditions, developments and courses of action that may or not occur or come to be. There can be no assurance that the underlying assumptions, opinions, estimates, plans, beliefs and expectations will prove to be correct and, accordingly, no assurance that the future performance, events, outcomes or circumstances expressed or implied in the forward-looking statements herein will occur or be realized. Actual results will differ, and the differences may be material and adverse to the Company.
In addition to the other factors and assumptions that may be identified herein, material factors and assumptions used to develop the forward-looking statements contained in this news release include, among other things, assumptions, opinions, estimates, plans, beliefs and expectations regarding: the effectiveness of our retail cannabis and pharmacy strategy; our ability to identify and consummate accretive acquisitions, expand our store network within budgeted costs and timelines, drive same-store sales growth, improve margins and generate new revenue streams; our ability to obtain additional licenses, authorizations and regulatory approvals (including any required approvals of the TSX Venture Exchange) as and when required to fit our growth and business plan; the size of the cannabis retail market and estimated portion currently unserved, and the migration of customers from the illicit market to legal market; our ability to capture additional market share; our ability to attract franchisees to the Shiny Health’s brand and model, and the terms of franchise arrangements; the number, type and locations of new stores; the applicability and relevance of our experience in existing centers and locations to new centers and locations; our ability to influence our customer purchase decisions; our ability to maintain, enhance, and grow our appeal within our addressable market, and to customize products and inventory for the market that resonate with our target customer base; our ability to source product that is key to our menu offerings; our ability to leverage our landlord network and build a flexible lease portfolio; our ability to manage costs and drive operating efficiencies; our ability to retain key management and non-management personnel, and to hire, train and motivate staff; the availability of capital, and our ability to obtain any required external financing on acceptable terms; our competitive strengths and the impact of competition; the accuracy of our financial models; trends in the retail cannabis and pharmacy sectors; the regulatory framework applicable to the retail cannabis and pharmacy industries in Canada, and the direction of any changes in that framework and underlying laws; and general economic, political and social conditions affecting the retail cannabis and pharmacy businesses.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that will cause actual results to differ from those indicated, suggested or anticipated in the forward-looking statements, and the differences may be material. Readers must therefore exercise caution and not rely on forward-looking statements, which rest on assumptions, opinions, estimates, plans, beliefs and expectations as of the date made that may change, and are in any event not a guarantee of future performance or a promise of any future outcomes. We believe such risks, uncertainties and other factors to include, without limitation, the following: risks associated with the retail cannabis and pharmacy industries generally; adverse changes in the general economic or market conditions, and to customer spending in the centers where we operate; unforeseen obstacles that prevent, delay or otherwise compromise the execution of our growth plan; inability to obtain additional licenses and authorizations (and other needed regulatory approvals) as and when required to fit our growth and business plan; ineffectively managing our growth; failure to secure desirable store locations; inability to secure leasehold premises for new stores on acceptable terms, risks associated with leasing retail space; adverse changes to the regulatory framework applicable to the retail cannabis and pharmacy industries in Canada, or to other laws and regulations affecting our business (including taxes); unanticipated diminishment of the Shiny Health or mīhī brands or any trademark protections; negative publicity for us or our business; marketing strategies that are less successful than expected; our highly competitive industry and the relative size and resources of some of our competitors; being unable to successfully open and operate new stores; profitability erosion from unexpected cost increases; slower profitability of new stores; failure to identify, recruit and contract with a sufficient number of qualified franchise partners; lack of access to capital to fund expansion, or more costly financing terms than expected; a data security breach that results in improper use or disclosure of confidential customer or employee information; risks associated with industry consolidation; loss of key management or other key personnel, or unexpected difficulty in attracting, training and/or motivating staff as necessary to execute our business plan; unexpected challenges in growing sales or connecting with our customer base; inability to meet other financial targets; any material claims made against us, which could result in litigation; insolvency risks with parties with whom we do business; increased expenses of being a public company; the forward-looking statements contained in this presentation proving to be inaccurate and incorrect despite there being a reasonable basis therefor at the time they were made; and such other risks, uncertainties and other factors as may be discussed or set out from time-to-time in Shiny Health’s public disclosure documents (including, without limitation, those risks identified in the Company’s management’s discussion and analysis filed by the Company with applicable securities regulatory authorities in Canada and available under its issuer profile on SEDAR at
The foregoing lists of material assumptions and risks, uncertainties and other factors are not exhaustive. The forward-looking statements contained herein speak only as of the date of this news release. The Company disclaims any intention, obligation or undertaking to update or revise any forward looking statements, whether as a result of new information, future events or otherwise, or to explain any difference between actual results and those indicated, suggested or anticipated in any forward looking statements, except as may be required under applicable securities laws.
All forward-looking statements contained in this news release and in any related reports or disclosures filed or issued by the Company, or made by the Company’s directors, officers and other persons authorized to speak on its behalf regarding the subject matter hereof, are expressly qualified by this cautionary statement.
SOURCE Shiny Health & Wellness Corp.
View original content to download multimedia:
Related Quotes
The first half of the year saw the benchmark S&P 500 (SNPINDEX: ^GSPC) produce its worst return since 1970. With the S&P 500 and Nasdaq respectively declining 24% and 34%, respectively, at their peaks, both indexes have firmly entered bear market territory. Given the heightened volatility and uncertainty that accompanies bear markets, it has a lot of investors wondering where the market will bottom.
It is the worst year for buying the stock-market dip since the 1930s. Instead of rebounding after a tumble, stocks have continued to fall, denting a strategy that soared in popularity over the past decade.
Cathie Wood's Ark Innovation ETF, which focuses on such stocks, has plunged by nearly 75% from its early 2021 peak, and some individual companies have fallen further. Advanced Micro Devices (NASDAQ: AMD),  Meta Platforms (NASDAQ: META), and Twilio (NYSE: TWLO) are likely three such stocks. Jake Lerch (Advanced Micro Devices): There's plenty of carnage in the stock market among tech stocks, and AMD is no exception.
The shipping company has developed a reputation as one of the best dividend stocks around
KEY WORDS “I think we’re giving Powell too much praise. … The last two years are one of the biggest policy mistakes in the 110-year history of the Fed by staying so easy when everything was booming.
Federal Reserve officials have a busy week of speeches ahead. Investors are desperate for more information on the future of rates.
Stocks have taken a bumpy ride this year. The S&P 500 was in a free fall for the first six months of 2022, tumbling about 24% from peak to trough on fears that rising interest rates to combat inflation could cause a recession. With the market growing fearful again, our contributors think that some stocks are starting to look like great bargains.
Dividends can be used to create passive income in an investment portfolio or grow wealth over the long term through reinvestment. Knowing how to live off dividends may be central to your retirement planning strategy if you want to avoid … Continue reading → The post How Much Do You Need to Live Off Dividends? appeared first on SmartAsset Blog.
Investing for the long term is the best way to grow your wealth. And these three stocks can help you do it.
(Bloomberg) — Week by week, the bond-market crash just keeps getting worse and there’s no clear end in sight.Most Read from BloombergBank of England Says Paper Banknotes Only Good for One More WeekThe Great Bond Bubble Is ‘Poof, Gone’ in Worst Year Since 1949‘Read Putin More Often and Carefully,’ Lavrov Tells the WorldUK Market Plunge Sparks Talk of Emergency BOE Rate HikeWith central banks worldwide aggressively ratcheting up interest rates in the face of stubbornly high inflation, prices are
AT&T (NYSE: T) and IBM (NYSE: IBM) both underwent dramatic transformations over the past year. AT&T divested DirecTV, merged WarnerMedia with Discovery to create Warner Bros. Discovery (NASDAQ: WBD) , and sold many of its non-core assets to prioritize the growth of its core telecom business.
The iconic automaker will report weak results this quarter, but Ford stock still looks as attractive as ever.
The Novavax (NASDAQ: NVAX) rollercoaster has been a wild one. The stock soared more than 2,700% in 2020 after the company received $1.6 billion from the U.S. government to develop the COVID-19 vaccine we now know as Nuvaxovid. Unfortunately, Novavax didn't receive authorization to sell its vaccine in the U.S. until this July.
Today, with the stock market in meltdown mode, it’s natural to look back at other times of financial woe. The market environment in the 1970s can be particularly instructive.
Yes, there's a lot of economic concerns, but this is a buying opportunity (and things aren't nearly as bad as they seem).
These are the dividend stocks in the Russell 1000 with the highest forward dividend yield for September.
Homeowners beware. But don't panic, either.
Is the EV stock on track for more incredible gains, or is this a hype bubble that's bound to burst?
Tesla's billionaire CEO has a chance to expand his influence, but he can also give his critics new ammunition.
Just about all growth stocks were hammered this year. Since they peaked in the first quarter of 2021, the lack of favorable momentum toward U.S. federal legalization has taken a major toll on their stock prices. But these companies are growing revenue at a healthy rate that could make them top cannabis players by the time U.S. federal legalization happens.


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort